Massachusetts Financial Services’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $426M | Sell |
|
|||||
|
2025
Q4 | $402M | Buy |
|
|||||
|
2025
Q3 | $374M | Sell |
|
|||||
|
2025
Q2 | $328M | Buy |
|
|||||
|
2025
Q1 | $293M | Buy |
|
|||||
|
2024
Q4 | $257M | Buy |
|
|||||
|
2024
Q3 | $279M | Buy |
|
|||||
|
2024
Q2 | $233M | Buy |
|
|||||
|
2024
Q1 | $245M | Buy |
|
|||||
|
2023
Q4 | $191M | Buy |
|
|||||
|
2023
Q3 | $118M | Buy |
|
|||||
|
2023
Q2 | $97.1M | Sell |
|
|||||
|
2023
Q1 | $146M | Buy |
|
|||||
|
2022
Q4 | $164M | Buy |
|
|||||
|
2022
Q3 | $122M | Buy |
|
|||||
|
2022
Q2 | $77.6M | Buy |
|
|||||
|
2022
Q1 | $90.5M | Buy |
|
|||||
|
2021
Q4 | $101M | Buy |
|
|||||
|
2021
Q3 | $119M | Buy |
|
|||||
|
2021
Q2 | $92.1M | Sell |
|
|||||
|
2021
Q1 | $91.6M | Buy |
|
|||||
|
2020
Q4 | $117M | Buy |
|
|||||
|
2020
Q3 | $103M | Buy |
|